Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Anil Sood
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Anatomy
Living Beings
Chemicals & Drugs
Procedures
Physiology
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
33
Sorosky, Joel
31
Gershenson, David
31
Landen, Charles
29
Lin, Yvonne
28
Kamat, Aparna
28
Buller, Richard
26
Lutgendorf, Susan
25
Coleman, Robert
24
Merritt, William
22
Han, Liz
20
Lopez-Berestein, Gabriel
19
Spannuth, Whitney
16
Lu, Chunhua
16
Anderson, Barrie
15
Mangala, Lingegowda
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Anil Sood (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Cai You-Qing; Chen Shao-Rui; Han Hee-Dong; Sood Anil K; Lopez-Berestein Gabriel; Pan Hui-Lin
Role of M2, M3, and M4 muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats.
Journal of neurochemistry 2009;111(4):1000-10.
-
2009: Lee Jeong-Won; Han Hee Dong; Shahzad Mian M K; Kim Seung Wook; Mangala Lingegowda S; Nick Alpa M; Lu Chunhua; Langley Robert R; Schmandt Rosemarie; Kim Hye-Sun; Mao Shenlan; Gooya John; Fazenbaker Christine; Jackson Dowdy; Tice David A; Landen Charles N; Coleman Robert L; Sood Anil K
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma.
Journal of the National Cancer Institute 2009;101(17):1193-205.
-
2009: Tao Xia; Sood Anil K; Deavers Michael T; Schmeler Kathleen M; Nick Alpa M; Coleman Robert L; Milojevic Ljiljana; Gershenson David M; Brown Jubilee
Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors.
Gynecologic oncology 2009;114(3):431-6.
-
2009: Merritt William M; Danes Christopher G; Shahzad Mian M K; Lin Yvonne G; Kamat Aparna A; Han Liz Y; Spannuth Whitney A; Nick Alpa M; Mangala Lingegowda S; Stone Rebecca L; Kim Hye Sun; Gershenson David M; Jaffe Robert B; Coleman Robert L; Chandra Joya; Sood Anil K
Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma.
Cancer biology & therapy 2009;8(16):1596-603.
-
2009: Gershenson David M; Sun Charlotte C; Bodurka Diane; Coleman Robert L; Lu Karen H; Sood Anil K; Deavers Michael; Malpica Anais L; Kavanagh John J
Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
Gynecologic oncology 2009;114(1):48-52.
-
2009: Moroney John W; Sood Anil K; Coleman Robert L
Aflibercept in epithelial ovarian carcinoma.
Future oncology (London, England) 2009;5(5):591-600.
-
2009: Mangala Lingegowda S; Zuzel Vesna; Schmandt Rosemarie; Leshane Erik S; Halder Jyotsna B; Armaiz-Pena Guillermo N; Spannuth Whitney A; Tanaka Takemi; Shahzad Mian M K; Lin Yvonne G; Nick Alpa M; Danes Christopher G; Lee Jeong-Won; Jennings Nicholas B; Vivas-Mejia Pablo E; Wolf Judith K; Coleman Robert L; Siddik Zahid H; Lopez-Berestein Gabriel; Lutsenko Svetlana; Sood Anil K
Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(11):3770-80.
-
2009: Kamat Aparna A; Coffey Donna; Merritt William M; Nugent Elizabeth; Urbauer Diana; Lin Yvonne G; Edwards Creighton; Broaddus Russell; Coleman Robert L; Sood Anil K
EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.
Cancer 2009;115(12):2684-92.
-
2009: Shahzad Mian M K; Lu Chunhua; Lee Jeong-Won; Stone Rebecca L; Mitra Rahul; Mangala Lingegowda S; Lu Yiling; Baggerly Keith A; Danes Christopher G; Nick Alpa M; Halder Jyotsnabaran; Kim Hye-Sun; Vivas-Mejia Pablo; Landen Charles N; Lopez-Berestein Gabriel; Coleman Robert L; Sood Anil K
Dual targeting of EphA2 and FAK in ovarian carcinoma.
Cancer biology & therapy 2009;8(11):1027-34.
-
2009: Armaiz-Pena Guillermo N; Mangala Lingegowda S; Spannuth Whitney A; Lin Yvonne G; Jennings Nicholas B; Nick Alpa M; Langley Robert R; Schmandt Rosemarie; Lutgendorf Susan K; Cole Steven W; Sood Anil K
Estrous cycle modulates ovarian carcinoma growth.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(9):2971-8.
-
2009: Lee Jeong-Won; Shahzad Mian M K; Lin Yvonne G; Armaiz-Pena Guillermo; Mangala Lingegowda S; Han Hee-Dong; Kim Hye-Sun; Nam Eun Ji; Jennings Nicholas B; Halder Jyotsnabaran; Nick Alpa M; Stone Rebecca L; Lu Chunhua; Lutgendorf Susan K; Cole Steve W; Lokshin Anna E; Sood Anil K
Surgical stress promotes tumor growth in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(8):2695-702.
-
2009: Brown Jubilee; Sood Anil K; Deavers Michael T; Milojevic Ljiljana; Gershenson David M
Patterns of metastasis in sex cord-stromal tumors of the ovary: Can routine staging lymphadenectomy be omitted?
Gynecologic oncology 2009;113(1):86-90.
-
2009: Lamkin Donald M; Spitz Douglas R; Shahzad Mian M K; Zimmerman Bridget; Lenihan Daniel J; Degeest Koen; Lubaroff David M; Shinn Eileen H; Sood Anil K; Lutgendorf Susan K
Glucose as a prognostic factor in ovarian carcinoma.
Cancer 2009;115(5):1021-7.
-
2009: Lutgendorf Susan K; DeGeest Koen; Sung Caroline Y; Arevalo Jesusa M; Penedo Frank; Lucci Joseph; Goodheart Michael; Lubaroff David; Farley Donna M; Sood Anil K; Cole Steve W
Depression, social support, and beta-adrenergic transcription control in human ovarian cancer.
Brain, behavior, and immunity 2009;23(2):176-83.
-
2009: Armaiz-Pena Guillermo N; Lutgendorf Susan K; Cole Steve W; Sood Anil K
Neuroendocrine modulation of cancer progression.
Brain, behavior, and immunity 2009;23(1):10-5.
-
2009: Ramachandran Vijaya; Arumugam Thiruvengadam; Langley Robert; Hwang Rosa F; Vivas-Mejia Pablo; Sood Anil K; Lopez-Berestein Gabriel; Logsdon Craig D
The ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment.
PloS one 2009;4(10):e7502.
-
2009: Mangala Lingegowda S; Han Hee Dong; Lopez-Berestein Gabriel; Sood Anil K
Liposomal siRNA for ovarian cancer.
Methods in molecular biology (Clifton, N.J.) 2009;555():29-42.
-
2008: Gray M J; Dallas N A; Van Buren G; Xia L; Yang A D; Somcio R J; Gaur P; Mangala L S; Vivas-Mejia P E; Fan F; Sanguino A M; Gallick G E; Lopez-Berestein G; Sood A K; Ellis L M
Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.
Oncogene 2008;27(57):7192-200.
-
2008: Lutgendorf Susan K; Lamkin Donald M; Jennings Nicholas B; Arevalo Jesusa M G; Penedo Frank; DeGeest Koen; Langley Robert R; Lucci Joseph A; Cole Steve W; Lubaroff David M; Sood Anil K
Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(21):6839-46.
-
2008: Villares Gabriel J; Zigler Maya; Wang Hua; Melnikova Vladislava O; Wu Hong; Friedman Ran; Leslie Michael C; Vivas-Mejia Pablo E; Lopez-Berestein Gabriel; Sood Anil K; Bar-Eli Menashe
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.
Cancer research 2008;68(21):9078-86.
-
2008: Landen Charles N; Kim Tae-Jin; Lin Yvonne G; Merritt William M; Kamat Aparna A; Han Liz Y; Spannuth Whitney A; Nick Alpa M; Jennnings Nicholas B; Kinch Michael S; Tice David; Sood Anil K
Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer.
Neoplasia (New York, N.Y.) 2008;10(11):1259-67.
-
2008: Lutgendorf Susan K; Weinrib Aliza Z; Penedo Frank; Russell Daniel; DeGeest Koen; Costanzo Erin S; Henderson Patrick J; Sephton Sandra E; Rohleder Nicolas; Lucci Joseph A; Cole Steven; Sood Anil K; Lubaroff David M
Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(29):4820-7.
-
2008: Nick Alpa M; Sood Anil K
The ROC 'n' role of the multiplex assay for early detection of ovarian cancer.
Nature clinical practice. Oncology 2008;5(10):568-9.
-
2008: Lin Yvonne G; Immaneni Anand; Merritt William M; Mangala Lingegowda S; Kim Seung Wook; Shahzad Mian M K; Tsang Yvonne T M; Armaiz-Pena Guillermo N; Lu Chunhua; Kamat Aparna A; Han Liz Y; Spannuth Whitney A; Nick Alpa M; Landen Charles N; Wong Kwong K; Gray Michael J; Coleman Robert L; Bodurka Diane C; Brinkley William R; Sood Anil K
Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(17):5437-46.
-
2008: Lutgendorf Susan K; Lamkin Donald M; DeGeest Koen; Anderson Barrie; Dao Minh; McGinn Stephanie; Zimmerman Bridget; Maiseri Heena; Sood Anil K; Lubaroff David M
Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients.
Brain, behavior, and immunity 2008;22(6):890-900.
-
2008: Guan Hui; Zhou Zhichao; Gallick Gary E; Jia Shu-Fang; Morales Jaime; Sood Anil K; Corey Seth J; Kleinerman Eugenie S
Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma.
Molecular cancer therapeutics 2008;7(7):1807-16.
-
2008: Hwang Jee Young; Mangala Lingegowda S; Fok Jansina Y; Lin Yvonne G; Merritt William M; Spannuth Whitney A; Nick Alpa M; Fiterman Derek J; Vivas-Mejia Pablo E; Deavers Michael T; Coleman Robert L; Lopez-Berestein Gabriel; Mehta Kapil; Sood Anil K
Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.
Cancer research 2008;68(14):5849-58.
-
2008: Sood Anil K; Birrer Michael J
Highlights from the 2008 Annual Meeting of the American Association for Cancer Research.
Gynecologic oncology 2008;110(1):5-6.
-
2008: Lu Chunhua; Shahzad Mian M K; Wang Hua; Landen Charles N; Kim Seung W; Allen Julie; Nick Alpa M; Jennings Nicholas; Kinch Michael S; Bar-Eli Menashe; Sood Anil K
EphA2 overexpression promotes ovarian cancer growth.
Cancer biology & therapy 2008;7(7):1098-103.
-
2008: Han Liz Y; Fletcher Mavis S; Urbauer Diana L; Mueller Peter; Landen Charles N; Kamat Aparna A; Lin Yvonne G; Merritt William M; Spannuth Whitney A; Deavers Michael T; De Geest Koen; Gershenson David M; Lutgendorf Susan K; Ferrone Soldano; Sood Anil K
HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3372-9.
-
2008: Thaker Premal H; Sood Anil K
Neuroendocrine influences on cancer biology.
Seminars in cancer biology 2008;18(3):164-70.
-
2008: Verma Amit; Guha Sushovan; Diagaradjane Parmeswaran; Kunnumakkara Ajaikumar B; Sanguino Angela M; Lopez-Berestein Gabriel; Sood Anil K; Aggarwal Bharat B; Krishnan Sunil; Gelovani Juri G; Mehta Kapil
Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(8):2476-83.
-
2008: Lu Chunhua; Thaker Premal H; Lin Yvonne G; Spannuth Whitney; Landen Charles N; Merritt William M; Jennings Nicholas B; Langley Robert R; Gershenson David M; Yancopoulos George D; Ellis Lee M; Jaffe Robert B; Coleman Robert L; Sood Anil K
Impact of vessel maturation on antiangiogenic therapy in ovarian cancer.
American journal of obstetrics and gynecology 2008;198(4):477.e1-9; discussion 477.e9-10.
-
2008: Spannuth Whitney A; Sood Anil K; Coleman Robert L
Angiogenesis as a strategic target for ovarian cancer therapy.
Nature clinical practice. Oncology 2008;5(4):194-204.
-
2008: Sanguino Angela; Lopez-Berestein Gabriel; Sood Anil K
Strategies for in vivo siRNA delivery in cancer.
Mini reviews in medicinal chemistry 2008;8(3):248-55.
-
2008: Merritt William M; Lin Yvonne G; Spannuth Whitney A; Fletcher Mavis S; Kamat Aparna A; Han Liz Y; Landen Charles N; Jennings Nicholas; De Geest Koen; Langley Robert R; Villares Gabriel; Sanguino Angela; Lutgendorf Susan K; Lopez-Berestein Gabriel; Bar-Eli Menashe M; Sood Anil K
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.
Journal of the National Cancer Institute 2008;100(5):359-72.
-
2008: Landen Charles N; Birrer Michael J; Sood Anil K
Early events in the pathogenesis of epithelial ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):995-1005.
-
2008: Gray Michael J; Van Buren George; Dallas Nikolaos A; Xia Ling; Wang Xuemei; Yang Anthony D; Somcio Ray J; Lin Yvonne G; Lim Sherry; Fan Fan; Mangala Lingegowda S; Arumugam Thiruvengadam; Logsdon Craig D; Lopez-Berestein Gabriel; Sood Anil K; Ellis Lee M
Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Journal of the National Cancer Institute 2008;100(2):109-20.
-
2008: Lamkin Donald M; Lutgendorf Susan K; McGinn Stephanie; Dao Minh; Maiseri Heena; DeGeest Koen; Sood Anil K; Lubaroff David M
Positive psychosocial factors and NKT cells in ovarian cancer patients.
Brain, behavior, and immunity 2008;22(1):65-73.
-
2008: Stany Michael P; Bonome Tomas; Wamunyokoli Fred; Zorn Kristen; Ozbun Laurent; Park Dong-Choon; Hao Ke; Boyd Jeff; Sood Anil K; Gershenson David M; Berkowitz Ross S; Mok Samuel C; Birrer Michael J
Classification of ovarian cancer: a genomic analysis.
Advances in experimental medicine and biology 2008;622():23-33.
-
2007: Kamat Aparna A; Merritt William M; Coffey Donna; Lin Yvonne G; Patel Pooja R; Broaddus Russell; Nugent Elizabeth; Han Liz Y; Landen Charles N; Spannuth Whitney A; Lu Chunhua; Coleman Robert L; Gershenson David M; Sood Anil K
Clinical and biological significance of vascular endothelial growth factor in endometrial cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(24):7487-95.
-
2007: Fernández Ariel; Sanguino Angela; Peng Zhenghong; Ozturk Eylem; Chen Jianping; Crespo Alejandro; Wulf Sarah; Shavrin Aleksander; Qin Chaoping; Ma Jianpeng; Trent Jonathan; Lin Yvonne; Han Hee-Dong; Mangala Lingegowda S; Bankson James A; Gelovani Juri; Samarel Allen; Bornmann William; Sood Anil K; Lopez-Berestein Gabriel
An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic.
The Journal of clinical investigation 2007;117(12):4044-54.
-
2007: Halder Jyotsnabaran; Lin Yvonne G; Merritt William M; Spannuth Whitney A; Nick Alpa M; Honda Toshiyuki; Kamat Aparna A; Han Liz Y; Kim Tae Jin; Lu Chunhua; Tari Ana M; Bornmann William; Fernandez Ariel; Lopez-Berestein Gabriel; Sood Anil K
Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma.
Cancer research 2007;67(22):10976-83.
-
2007: Landen Charles N; Lin Yvonne G; Armaiz Pena Guillermo N; Das Pamela D; Arevalo Jesusa M; Kamat Aparna A; Han Liz Y; Jennings Nicholas B; Spannuth Whitney A; Thaker Premal H; Lutgendorf Susan K; Savary Cherylyn A; Sanguino Angela M; Lopez-Berestein Gabriel; Cole Steve W; Sood Anil K
Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer.
Cancer research 2007;67(21):10389-96.
-
2007: Kim Tae Jin; Ravoori Murali; Landen Charles N; Kamat Aparna A; Han Liz Y; Lu Chunhua; Lin Yvonne G; Merritt William M; Jennings Nicholas; Spannuth Whitney A; Langley Robert; Gershenson David M; Coleman Robert L; Kundra Vikas; Sood Anil K
Antitumor and antivascular effects of AVE8062 in ovarian carcinoma.
Cancer research 2007;67(19):9337-45.
-
2007: Nilsson Monique B; Armaiz-Pena Guillermo; Takahashi Rie; Lin Yvonne G; Trevino Jose; Li Yang; Jennings Nicholas; Arevalo Jesusa; Lutgendorf Susan K; Gallick Gary E; Sanguino Angela M; Lopez-Berestein Gabriel; Cole Steven W; Sood Anil K
Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism.
The Journal of biological chemistry 2007;282(41):29919-26.
-
2007: Lu Chunhua; Kamat Aparna A; Lin Yvonne G; Merritt William M; Landen Charles N; Kim Tae Jin; Spannuth Whitney; Arumugam Thiru; Han Liz Y; Jennings Nicholas B; Logsdon Craig; Jaffe Robert B; Coleman Robert L; Sood Anil K
Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(14):4209-17.
-
2007: Landen Charles N; Lin Yvonne G; Immaneni Anand; Deavers Michael T; Merritt William M; Spannuth Whitney A; Bodurka Diane C; Gershenson David M; Brinkley William R; Sood Anil K
Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(14):4098-104.
-
2007: Lin Yvonne G; Kunnumakkara Ajaikumar B; Nair Asha; Merritt William M; Han Liz Y; Armaiz-Pena Guillermo N; Kamat Aparna A; Spannuth Whitney A; Gershenson David M; Lutgendorf Susan K; Aggarwal Bharat B; Sood Anil K
Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3423-30.
-
2007: Spannuth Whitney A; Thaker Premal H; Sood Anil K
Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer.
American journal of obstetrics and gynecology 2007;196(4):e6-9.
-
2007: Kumar S R; Masood R; Spannuth W A; Singh J; Scehnet J; Kleiber G; Jennings N; Deavers M; Krasnoperov V; Dubeau L; Weaver F A; Sood A K; Gill P S
The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome.
British journal of cancer 2007;96(7):1083-91.
-
2007: Milam Michael R; Sood Anil K; King Sara; Bassett Roland L; Lu Karen H; Slomovitz Brian M; Coleman Robert L; Ramirez Pedro T
Supracervical hysterectomy in patients with advanced epithelial ovarian cancer.
Obstetrics and gynecology 2007;109(3):641-6.
-
2007: Frumovitz Michael; Sood Anil K
Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies.
Gynecologic oncology 2007;104(3):768-78.
-
2007: Thaker Premal H; Lutgendorf Susan K; Sood Anil K
The neuroendocrine impact of chronic stress on cancer.
Cell cycle (Georgetown, Tex.) 2007;6(4):430-3.
-
2007: Lu Chunhua; Bonome Tomas; Li Yang; Kamat Aparna A; Han Liz Y; Schmandt Rosemarie; Coleman Robert L; Gershenson David M; Jaffe Robert B; Birrer Michael J; Sood Anil K
Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma.
Cancer research 2007;67(4):1757-68.
-
2007: Kamat Aparna A; Kim Tae Jin; Landen Charles N; Lu Chunhua; Han Liz Y; Lin Yvonne G; Merritt William M; Thaker Premal H; Gershenson David M; Bischoff Farideh Z; Heymach John V; Jaffe Robert B; Coleman Robert L; Sood Anil K
Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer.
Cancer research 2007;67(1):281-8.
-
2007: Lin Yvonne G; Han Liz Y; Kamat Aparna A; Merritt William M; Landen Charles N; Deavers Michael T; Fletcher Mavis S; Urbauer Diana L; Kinch Michael S; Sood Anil K
EphA2 overexpression is associated with angiogenesis in ovarian cancer.
Cancer 2007;109(2):332-40.
-
2007: Merritt William M; Sood Anil K
Markers of angiogenesis in ovarian cancer.
Disease markers 2007;23(5-6):419-31.
-
2006: Landen Charles N; Merritt William M; Mangala Lingegowda S; Sanguino Angela M; Bucana Corazon; Lu Chunhua; Lin Yvonne G; Han Liz Y; Kamat Aparna A; Schmandt Rosemarie; Coleman Robert L; Gershenson David M; Lopez-Berestein Gabriel; Sood Anil K
Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer.
Cancer biology & therapy 2006;5(12):1708-13.
-
2006: Landen Charles N; Lu Chunhua; Han Liz Y; Coffman Karen T; Bruckheimer Elizabeth; Halder Jyotsnabaran; Mangala Lingegowda S; Merritt William M; Lin Yvonne G; Gao Changhou; Schmandt Rosemarie; Kamat Aparna A; Li Yang; Thaker Premal; Gershenson David M; Parikh Nila U; Gallick Gary E; Kinch Michael S; Sood Anil K
Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
Journal of the National Cancer Institute 2006;98(21):1558-70.
-
2006: Coleman Robert L; Sood Anil K
Historical progress in the initial management of ovarian cancer: intraperitoneal chemotherapy.
Current oncology reports 2006;8(6):455-64.
-
2006: Merritt William M; Thaker Premal H; Landen Charles N; Deavers Michael T; Fletcher Mavis S; Lin Yvonne G; Han Liz Y; Kamat Aparna A; Schmandt Rosemarie; Gershenson David M; Kinch Michael S; Sood Anil K
Analysis of EphA2 expression and mutant p53 in ovarian carcinoma.
Cancer biology & therapy 2006;5(10):1357-60.
-
2006: Kamat Aparna A; Bischoff Farideh Z; Dang Dianne; Baldwin Matthew F; Han Liz Y; Lin Yvonne G; Merritt William M; Landen Charles N; Lu Chunhua; Gershenson David M; Simpson Joe L; Sood Anil K
Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma.
Cancer biology & therapy 2006;5(10):1369-74.
-
2006: Kamat Aparna A; Sood Anil K; Dang Dianne; Gershenson David M; Simpson Joe L; Bischoff Farideh Z
Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.
Annals of the New York Academy of Sciences 2006;1075():230-4.
-
2006: Han Liz Y; Landen Charles N; Trevino Jose G; Halder Jyotsnabaran; Lin Yvonne G; Kamat Aparna A; Kim Tae-Jin; Merritt William M; Coleman Robert L; Gershenson David M; Shakespeare William C; Wang Yihan; Sundaramoorth Raji; Metcalf Chester A; Dalgarno David C; Sawyer Tomi K; Gallick Gary E; Sood Anil K
Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma.
Cancer research 2006;66(17):8633-9.
-
2006: Schmandt Rosemarie E; Bennett Marsha; Clifford Stephanie; Thornton Angela; Jiang Feng; Broaddus Russell R; Sun Charlotte C; Lu Karen H; Sood Anil K; Gershenson David M
The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary.
Cancer biology & therapy 2006;5(9):1136-41.
-
2006: Halder Jyotsnabaran; Kamat Aparna A; Landen Charles N; Han Liz Y; Lutgendorf Susan K; Lin Yvonne G; Merritt William M; Jennings Nicholas B; Chavez-Reyes Arturo; Coleman Robert L; Gershenson David M; Schmandt Rosemarie; Cole Steven W; Lopez-Berestein Gabriel; Sood Anil K
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(16):4916-24.
-
2006: Gershenson David M; Sun Charlotte C; Lu Karen H; Coleman Robert L; Sood Anil K; Malpica Anais; Deavers Michael T; Silva Elvio G; Bodurka Diane C
Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary.
Obstetrics and gynecology 2006;108(2):361-8.
-
2006: Thaker Premal H; Han Liz Y; Kamat Aparna A; Arevalo Jesusa M; Takahashi Rie; Lu Chunhua; Jennings Nicholas B; Armaiz-Pena Guillermo; Bankson James A; Ravoori Murali; Merritt William M; Lin Yvonne G; Mangala Lingegowda S; Kim Tae Jin; Coleman Robert L; Landen Charles N; Li Yang; Felix Edward; Sanguino Angela M; Newman Robert A; Lloyd Mary; Gershenson David M; Kundra Vikas; Lopez-Berestein Gabriel; Lutgendorf Susan K; Cole Steven W; Sood Anil K
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.
Nature medicine 2006;12(8):939-44.
-
2006: Kamat Aparna A; Fletcher Mavis; Gruman Lynn M; Mueller Peter; Lopez Adriana; Landen Charles N; Han Liz; Gershenson David M; Sood Anil K
The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1707-14.
-
2006: Han Liz Y; Landen Charles N; Kamat Aparna A; Lopez Adriana; Bender David P; Mueller Peter; Schmandt Rosemarie; Gershenson David M; Sood Anil K
Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(5):755-61.
-
2006: Sood Anil K; Bhatty Robert; Kamat Aparna A; Landen Charles N; Han Liz; Thaker Premal H; Li Yang; Gershenson David M; Lutgendorf Susan; Cole Steven W
Stress hormone-mediated invasion of ovarian cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(2):369-75.
-
2006: Kamat Aparna A; Feng Shu; Agoulnik Irina U; Kheradmand Farrah; Bogatcheva Natalia V; Coffey Donna; Sood Anil K; Agoulnik Alexander I
The role of relaxin in endometrial cancer.
Cancer biology & therapy 2006;5(1):71-7.
-
2005: Halder Jyotsnabaran; Landen Charles N; Lutgendorf Susan K; Li Yang; Jennings Nicholas B; Fan Dominic; Nelkin Gina M; Schmandt Rosemarie; Schaller Michael D; Sood Anil K
Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8829-36.
-
2005: Landen Charles N; Kinch Michael S; Sood Anil K
EphA2 as a target for ovarian cancer therapy.
Expert opinion on therapeutic targets 2005;9(6):1179-87.
-
2005: Bonome Tomas; Lee Ji-Young; Park Dong-Choon; Radonovich Mike; Pise-Masison Cindy; Brady John; Gardner Ginger J; Hao Ke; Wong Wing H; Barrett J Carl; Lu Karen H; Sood Anil K; Gershenson David M; Mok Samuel C; Birrer Michael J
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
Cancer research 2005;65(22):10602-12.
-
2005: Kamat Aparna A; Sood Anil K
The merits of vascular targeting for gynecologic malignancies.
Current oncology reports 2005;7(6):444-50.
-
2005: Lutgendorf Susan K; Sood Anil K; Anderson Barrie; McGinn Stephanie; Maiseri Heena; Dao Minh; Sorosky Joel I; De Geest Koen; Ritchie Justine; Lubaroff David M
Social support, psychological distress, and natural killer cell activity in ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7105-13.
-
2005: Landen Charles N; Chavez-Reyes Arturo; Bucana Corazon; Schmandt Rosemarie; Deavers Michael T; Lopez-Berestein Gabriel; Sood Anil K
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.
Cancer research 2005;65(15):6910-8.
-
2005: Thaker Premal H; Yazici Sertac; Nilsson Monique B; Yokoi Kenji; Tsan Rachel Z; He Junqin; Kim Sun-Jin; Fidler Isaiah J; Sood Anil K
Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4923-33.
-
2005: Thaker Premal H; Yokoi Kenji; Jennings Nicholas B; Li Yang; Rebhun Robert B; Rousseau Dennis L; Fan Dominic; Sood Anil K
Inhibition of experimental colon cancer metastasis by the GABA-receptor agonist nembutal.
Cancer biology & therapy 2005;4(7):753-8.
-
2005: Costanzo Erin S; Lutgendorf Susan K; Sood Anil K; Anderson Barrie; Sorosky Joel; Lubaroff David M
Psychosocial factors and interleukin-6 among women with advanced ovarian cancer.
Cancer 2005;104(2):305-13.
-
2005: Sood Anil K; Coleman Robert L; Wolf Judith K; Gershenson David M
Selected highlights from the 5th International Conference on Ovarian Cancer. Houston, TX, USA, 1-4 December 2004.
Expert opinion on pharmacotherapy 2005;6(7):1269-75.
-
2005: Sood Anil K; Abu-Rustum Nadeem R; Barakat Richard R; Bodurka Diane C; Brown Jubilee; Donato Michele L; Poynor Elizabeth A; Wolf Judith K; Gershenson David M
Fifth International Conference on Ovarian Cancer: challenges and opportunities.
Gynecologic oncology 2005;97(3):916-23.
-
2005: Sharma Navesh K; Sorosky Joel I; Bender David; Fletcher Mavis S; Sood Anil K
Malignant mixed mullerian tumor (MMMT) of the cervix.
Gynecologic oncology 2005;97(2):442-5.
-
2005: Sood Anil K; Cooper Brian C; Sorosky Joel I; Ramirez Pedro T; Levenback Charles
Novel modification of the vertical rectus abdominis myocutaneous flap for neovagina creation.
Obstetrics and gynecology 2005;105(3):514-8.
-
2004: Landen Charles N; Klingelhutz Al; Coffin Jeremy E; Sorosky Joel I; Sood Anil K
Genomic instability is associated with lack of telomerase activation in ovarian cancer.
Cancer biology & therapy 2004;3(12):1250-3.
-
2004: Sood Anil K; Coffin Jeremy E; Schneider Galen B; Fletcher Mavis S; DeYoung Barry R; Gruman Lynn M; Gershenson David M; Schaller Michael D; Hendrix Mary J C
Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.
The American journal of pathology 2004;165(4):1087-95.
-
2004: Sood Anil K; Lush Richard; Geisler John P; Shahin Mark S; Sanders Linda; Sullivan Dan; Buller Richard E; Sorosky Joel I
Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian carcinoma: results of a phase II trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):6080-5.
-
2004: Thaker Premal H; Deavers Michael; Celestino Joseph; Thornton Angela; Fletcher Mavis S; Landen Charles N; Kinch Michael S; Kiener Peter A; Sood Anil K
EphA2 expression is associated with aggressive features in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5145-50.
-
2004: Frausto Stephen D; Geisler John P; Fletcher Mavis S; Sood Anil K
Late recurrence of juvenile granulosa cell tumor of the ovary.
American journal of obstetrics and gynecology 2004;191(1):366-7.
-
2004: Sood Anil K; Fletcher Mavis S; Coffin Jeremy E; Yang Maria; Seftor Elisabeth A; Gruman Lynn M; Gershenson David M; Hendrix Mary J C
Functional role of matrix metalloproteinases in ovarian tumor cell plasticity.
American journal of obstetrics and gynecology 2004;190(4):899-909.
-
2004: Hsu Yvonne; Sood Anil K; Sorosky Joel I
Docetaxel versus paclitaxel for adjuvant treatment of ovarian cancer: case-control analysis of toxicity.
American journal of clinical oncology 2004;27(1):14-8.
-
2004: Eichholz Amy C; Van Voorhis Bradley J; Sorosky Joel I; Smith Brian J; Sood Anil K
Operative note dictation: should it be taught routinely in residency programs?
Obstetrics and gynecology 2004;103(2):342-6.
-
2003: Lowe M Patrick; Cooper Brian C; Sood Anil K; Davis William A; Syrop Craig H; Sorosky Joel I
Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypia.
Gynecologic oncology 2003;91(3):569-72.
-
2003: Geisler John P; Goodheart Michael J; Sood Anil K; Holmes Richard J; Hatterman-Zogg Melanie A; Buller Richard E
Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Cancer 2003;98(10):2199-206.
-
2003: Lutgendorf Susan K; Cole Steven; Costanzo Erin; Bradley Sarah; Coffin Jeremy; Jabbari Sarvenaz; Rainwater Kaitlin; Ritchie Justine M; Yang Maria; Sood Anil K
Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(12):4514-21.
-
2003: Sood Anil K; Hendrix Mary J C
The complexity of tumor vascularity.
Cancer biology & therapy 2003;2(3):257-8.
-
2003: Chun Mee Lee; Buekers Thomas E; Sood Anil K; Sorosky Joel I
Postoperative wound infection with Pasteurella multocida from a pet cat.
American journal of obstetrics and gynecology 2003;188(4):1115-6.
-
2002: Sood Anil K; Fletcher Mavis S; Zahn Chris M; Gruman Lynn M; Coffin Jeremy E; Seftor Elisbeth A; Hendrix Mary J C
The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy.
Cancer biology & therapy 2002;1(6):661-4.
-
2002: Sood Anil K; Nygaard Ingrid; Shahin Mark S; Sorosky Joel I; Lutgendorf Susan K; Rao Satish S C
Anorectal dysfunction after surgical treatment for cervical cancer.
Journal of the American College of Surgeons 2002;195(4):513-9.
-
2002: Cooper Brian C; Ritchie Justine M; Broghammer Carrie L W; Coffin Jeremy; Sorosky Joel I; Buller Richard E; Hendrix Mary J C; Sood Anil K
Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(10):3193-7.
-
2002: Sood Anil K; Coffin Jeremy; Jabbari Sarvenaz; Buller Richard E; Hendrix Mary J C; Klingelhutz Al
p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma.
Cancer biology & therapy 2002;1(5):511-7.
-
2002: Sood Anil K; Fletcher Mavis S; Gruman Lynn M; Coffin Jeremy E; Jabbari Sarvenaz; Khalkhali-Ellis Zhila; Arbour Nancy; Seftor Elisabeth A; Hendrix Mary J C
The paradoxical expression of maspin in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(9):2924-32.
-
2002: Lutgendorf Susan K; Johnsen Erica L; Cooper Brian; Anderson Barrie; Sorosky Joel I; Buller Richard E; Sood Anil K
Vascular endothelial growth factor and social support in patients with ovarian carcinoma.
Cancer 2002;95(4):808-15.
-
2002: Cooper Brian C; Sood Anil K; Davis Charles S; Ritchie Justine M; Sorosky Joel I; Anderson Barrie; Buller Richard E
Preoperative CA 125 levels: an independent prognostic factor for epithelial ovarian cancer.
Obstetrics and gynecology 2002;100(1):59-64.
-
2002: Eichholz Amy C; Mahavni Vikas; Sood Anil K
Allopathic and complementary alternatives to hormone replacement therapy.
Expert opinion on pharmacotherapy 2002;3(7):949-55.
-
2002: Goodheart Michael J; Vasef Mohammad A; Sood Anil K; Davis Charles S; Buller Richard E
Ovarian cancer p53 mutation is associated with tumor microvessel density.
Gynecologic oncology 2002;86(1):85-90.
-
2002: Bloss Jeffrey D; Blessing John A; Behrens Brent C; Mannel Robert S; Rader Janet S; Sood Anil K; Markman Maurie; Benda Jo
Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1832-7.
-
2002: Sood Anil K; Fletcher Mavis S; Hendrix Mary J C
The embryonic-like properties of aggressive human tumor cells.
Journal of the Society for Gynecologic Investigation 2002;9(1):2-9.
-
2002: Lutgendorf Susan K; Anderson Barrie; Ullrich Philip; Johnsen Erica L; Buller Richard E; Sood Anil K; Sorosky Joel I; Ritchie Justine
Quality of life and mood in women with gynecologic cancer: a one year prospective study.
Cancer 2002;94(1):131-40.
-
2002: Lowe M Patrick; Bender David; Sood Anil K; Davis William; Syrop Craig H; Sorosky Joel I
Two successful pregnancies after conservative treatment of endometrial cancer and assisted reproduction.
Fertility and sterility 2002;77(1):188-9.
-
2001: Sood A K; Shahin M S; Sorosky J I
Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy.
Gynecologic oncology 2001;83(3):599-600.
-
2001: Geisler J P; Sorosky J I; Duong H L; Buekers T E; Geisler M J; Sood A K; Anderson B; Buller R E
Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma.
Gynecologic oncology 2001;83(3):501-3.
-
2001: Mahavni V; Sood A K
Hormone replacement therapy and cancer risk.
Current opinion in oncology 2001;13(5):384-9.
-
2001: Sood A K; Holmes R; Hendrix M J; Buller R E
Application of the National Cancer Institute international criteria for determination of microsatellite instability in ovarian cancer.
Cancer research 2001;61(11):4371-4.
-
2001: Buller R E; Lallas T A; Shahin M S; Sood A K; Hatterman-Zogg M; Anderson B; Sorosky J I; Kirby P A
The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(4):831-8.
-
2001: Buller R E; Shahin M S; Holmes R W; Hatterman M; Kirby P A; Sood A K
p53 Mutations and microsatellite instability in ovarian cancer: Yin and yang.
American journal of obstetrics and gynecology 2001;184(5):891-902; discussion 902-3.
-
2001: Sood A K; Seftor E A; Fletcher M S; Gardner L M; Heidger P M; Buller R E; Seftor R E; Hendrix M J
Molecular determinants of ovarian cancer plasticity.
The American journal of pathology 2001;158(4):1279-88.
-
2001: Lowe M P; Ault K A; Sood A K
Recurrent carcinoma in situ of a neovagina.
Gynecologic oncology 2001;80(3):403-4.
-
2000: Shahin M S; Hughes J H; Sood A K; Buller R E
The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma.
Cancer 2000;89(9):2006-17.
-
2000: Minassian V A; Sood A K; Lowe P; Sorosky J I; Al-Jurf A S; Buller R E
Longterm central venous access in gynecologic cancer patients.
Journal of the American College of Surgeons 2000;191(4):403-9.
-
2000: Zhang S H; Sood A K; Sorosky J I; Anderson B; Buller R E
Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva.
Cancer 2000;89(7):1520-5.
-
2000: Lutgendorf S K; Anderson B; Rothrock N; Buller R E; Sood A K; Sorosky J I
Quality of life and mood in women receiving extensive chemotherapy for gynecologic cancer.
Cancer 2000;89(6):1402-11.
-
2000: Sood A K; Sorosky J I; Mayr N; Anderson B; Buller R E; Niebyl J
Cervical cancer diagnosed shortly after pregnancy: prognostic variables and delivery routes.
Obstetrics and gynecology 2000;95(6 Pt 1):832-8.
-
2000: Pertzborn S; Buekers T E; Sood A K
Hematogenous skin metastases from cervical cancer at primary presentation.
Gynecologic oncology 2000;76(3):416-7.
-
1999: Sood A K; Sorosky J I; Dolan M; Anderson B; Buller R E
Distant metastases in ovarian cancer: association with p53 mutations.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(9):2485-90.
-
1999: Sood A K; Sorosky J I; Squatrito R C; Skilling J S; Anderson B; Buller R E
Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies.
Neoplasia (New York, N.Y.) 1999;1(2):118-22.
-
1999: Buller R E; Sood A K; Lallas T; Buekers T; Skilling J S
Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer.
Journal of the National Cancer Institute 1999;91(4):339-46.
-
1998: Sood A K; Buller R E
Drug resistance in ovarian cancer: from the laboratory to the clinic.
Obstetrics and gynecology 1998;92(2):312-9.
-
1998: Sood A K; Sorosky J I
Invasive cervical cancer complicating pregnancy. How to manage the dilemma.
Obstetrics and gynecology clinics of North America 1998;25(2):343-52.
-
1998: Sood A K; Sorosky J I; Gelder M S; Buller R E; Anderson B; Wilkinson E J; Benda J A; Morgan L S
Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction.
Cancer 1998;82(9):1731-7.
-
1998: Buller R E; Skilling J S; Sood A K; Plaxe S; Baergen R N; Lager D J
Field cancerization: why late "recurrent" ovarian cancer is not recurrent.
American journal of obstetrics and gynecology 1998;178(4):641-9.
-
1998: Signore C C; Sood A K; Richards D S
Second-trimester vaginal bleeding: correlation of ultrasonographic findings with perinatal outcome.
American journal of obstetrics and gynecology 1998;178(2):336-40.
-
1998: Olson J K; Sood A K; Sorosky J I; Anderson B; Buller R E
Taxol hypersensitivity: rapid retreatment is safe and cost effective.
Gynecologic oncology 1998;68(1):25-8.
-
1997: Sood A K; Sorosky J I; Mayr N; Krogman S; Anderson B; Buller R E; Hussey D H
Radiotherapeutic management of cervical carcinoma that complicates pregnancy.
Cancer 1997;80(6):1073-8.
-
1997: Sood A K; Buller R E; Burger R A; Dawson J D; Sorosky J I; Berman M
Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome.
Obstetrics and gynecology 1997;90(3):441-7.
-
1997: Sorosky J I; Sood A K; Buekers T E
The use of chemotherapeutic agents during pregnancy.
Obstetrics and gynecology clinics of North America 1997;24(3):591-9.
-
1997: Rasmussen C C; Sood A K; Sorosky J I; Anderson B
Posterior exenteration through groin incision in a patient with stage III vulvar carcinoma.
Gynecologic oncology 1997;66(2):331-4.
-
1997: Sood A K; Skilling J S; Buller R E
Ovarian cancer genomic instability correlates with p53 frameshift mutations.
Cancer research 1997;57(6):1047-9.
-
1996: Sood A K; Sorosky J I; Krogman S; Anderson B; Benda J; Buller R E
Surgical management of cervical cancer complicating pregnancy: a case-control study.
Gynecologic oncology 1996;63(3):294-8.
-
1995: Sood A K; Yancey M; Richards D
Prediction of fetal macrosomia using humeral soft tissue thickness.
Obstetrics and gynecology 1995;85(6):937-40.
-
1995: Sood A K; Gelder M S; Huang S W; Morgan L S
Anaphylaxis to carboplatin following multiple previous uncomplicated courses.
Gynecologic oncology 1995;57(1):131-2.
Sign-in to see more
